Page last updated: 2024-10-19
phosphorylcholine and Nervous System Diseases
phosphorylcholine has been researched along with Nervous System Diseases in 8 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Ong, WY | 1 |
| Herr, DR | 1 |
| Farooqui, T | 1 |
| Ling, EA | 1 |
| Farooqui, AA | 1 |
| Gerdes, J | 1 |
| Gerdes, M | 1 |
| Beaumont, E | 1 |
| Cook, L | 1 |
| Dhanireddy, R | 1 |
| Kopleman, A | 1 |
| Jarret, R | 1 |
| Long, W | 7 |
| Kraybill, EN | 1 |
| Bose, CL | 1 |
| Corbet, AJ | 1 |
| Garcia-Prats, J | 1 |
| Asbill, D | 1 |
| Edwards, K | 1 |
| Courtney, SE | 1 |
| McMillan, D | 1 |
| Walter, D | 1 |
| Thompson, T | 1 |
| Sauve, R | 2 |
| Conway, B | 1 |
| Bard, H | 2 |
| Casiro, O | 2 |
| Bingham, W | 2 |
| MacMurray, B | 2 |
| Whitfield, M | 2 |
| Saigal, S | 2 |
| Vincer, M | 2 |
| Robertson, C | 2 |
| Sankaran, K | 1 |
| Gong, A | 1 |
| Anday, E | 1 |
| Boros, S | 1 |
| Bucciarelli, R | 1 |
| Burchfield, D | 1 |
| Zucker, J | 1 |
| Derleth, D | 1 |
| Stevenson, D | 1 |
| Pauly, T | 1 |
Reviews
1 review available for phosphorylcholine and Nervous System Diseases
Trials
7 trials available for phosphorylcholine and Nervous System Diseases
| Article | Year |
|---|
Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies | 1995 |
Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up St | 1995 |
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female | 1995 |
One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up GroThe Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up St | 1995 |
One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up St | 1995 |
One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up St | 1995 |
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Fem | 1995 |